About FDA

Division of Dermatology and Dental Products (DDDP)

Director: Susan Walker, M.D.
Deputy Director: Stanka Kukich, M.D.
Deputy Director for Safety: Tatiana Oussova, M.D.

Chief, Project Management Staff: Barbara Gould
Team Leader, Project Management Staff: Vacant


The Division of Dermatology and Dental Products (DDDP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologics Licensing Applications (BLAs) for drugs and biologics intended for the prevention and treatment of dermatology and dental conditions including: 

  • Acne
  • Actinic keratosis
  • Aesthetic indications (facial lines, subcutaneous fat, scarring, etc.)
  • Atopic dermatitis
  • Condyloma acuminate (genital warts)
  • Dental caries
  • Gingivitis
  • Psoriasis
  • Rosacea
  • Superficial basal cell carcinoma
  • Wound healing/ulcers
  • Xerostomia (dry mouth)


Mailing Address:
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Dermatology and Dental Products
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-2110
Fax: (301) 796-9895


Page Last Updated: 03/29/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English